318 related articles for article (PubMed ID: 25012616)
1. Therapeutic perspectives of drugs targeting Toll-like receptors based on immune physiopathology theory of Alzheimer's disease.
Schneider AR; Sari Y
CNS Neurol Disord Drug Targets; 2014; 13(5):909-20. PubMed ID: 25012616
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-β, tau, and the cholinergic system in Alzheimer's disease: seeking direction in a tangle of clues.
Majdi A; Sadigh-Eteghad S; Rahigh Aghsan S; Farajdokht F; Vatandoust SM; Namvaran A; Mahmoudi J
Rev Neurosci; 2020 May; 31(4):391-413. PubMed ID: 32017704
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptors in Alzheimer's disease: a therapeutic perspective.
Gambuzza ME; Sofo V; Salmeri FM; Soraci L; Marino S; Bramanti P
CNS Neurol Disord Drug Targets; 2014; 13(9):1542-58. PubMed ID: 25106635
[TBL] [Abstract][Full Text] [Related]
5. Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies.
Chen Y; Fu AKY; Ip NY
Pharmacol Ther; 2019 Mar; 195():186-198. PubMed ID: 30439458
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
Behl T; Kaur I; Fratila O; Brata R; Bungau S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
[TBL] [Abstract][Full Text] [Related]
7. Role of tau protein in Alzheimer's disease: The prime pathological player.
Muralidar S; Ambi SV; Sekaran S; Thirumalai D; Palaniappan B
Int J Biol Macromol; 2020 Nov; 163():1599-1617. PubMed ID: 32784025
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
Pinheiro L; Faustino C
Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's Disease: Advances in Drug Development.
Piton M; Hirtz C; Desmetz C; Milhau J; Lajoix AD; Bennys K; Lehmann S; Gabelle A
J Alzheimers Dis; 2018; 65(1):3-13. PubMed ID: 30040716
[TBL] [Abstract][Full Text] [Related]
10. Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease.
Kulshreshtha A; Piplani P
Neurol Sci; 2016 Sep; 37(9):1403-35. PubMed ID: 27250365
[TBL] [Abstract][Full Text] [Related]
11. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
12. Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.
Wang H; Liu X; Chen S; Ye K
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12427-E12434. PubMed ID: 30530690
[TBL] [Abstract][Full Text] [Related]
13. Biological Signatures of Alzheimer's Disease.
Sharma P; Sharma A; Fayaz F; Wakode S; Pottoo FH
Curr Top Med Chem; 2020; 20(9):770-781. PubMed ID: 32108008
[TBL] [Abstract][Full Text] [Related]
14. A three-dimensional human neural cell culture model of Alzheimer's disease.
Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
[TBL] [Abstract][Full Text] [Related]
15. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.
Ashrafian H; Zadeh EH; Khan RH
Int J Biol Macromol; 2021 Jan; 167():382-394. PubMed ID: 33278431
[TBL] [Abstract][Full Text] [Related]
16. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease.
Mroczko B; Groblewska M; Litman-Zawadzka A; Kornhuber J; Lewczuk P
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954063
[TBL] [Abstract][Full Text] [Related]
17. Combining in vitro and in silico Approaches to Find New Candidate Drugs Targeting the Pathological Proteins Related to the Alzheimer's Disease.
Li H; Wang X; Yu H; Zhu J; Jin H; Wang A; Yang Z
Curr Neuropharmacol; 2018; 16(6):758-768. PubMed ID: 29086699
[TBL] [Abstract][Full Text] [Related]
18. Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease.
Cho JE; Kim JR
Recent Pat CNS Drug Discov; 2011 Sep; 6(3):222-33. PubMed ID: 21834780
[TBL] [Abstract][Full Text] [Related]
19. Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?
Doig AJ; Del Castillo-Frias MP; Berthoumieu O; Tarus B; Nasica-Labouze J; Sterpone F; Nguyen PH; Hooper NM; Faller P; Derreumaux P
ACS Chem Neurosci; 2017 Jul; 8(7):1435-1437. PubMed ID: 28586203
[TBL] [Abstract][Full Text] [Related]
20. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.
Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK
Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
